Care/of LegitScript and Accreditation Status: Is Care/of Legit?

What Is LegitScript and Why Does It Matter for Supplement Brands?

LegitScript is an independent compliance and monitoring company that certifies online pharmacies, telehealth platforms, and health-related websites. A LegitScript certification tells consumers and payment processors that a platform meets defined legal, safety, and transparency standards. For online pharmacies dispensing controlled substances or prescription drugs, LegitScript certification is practically mandatory to maintain merchant accounts with Visa, Mastercard, and Google Ads.

For supplement-only brands like Care/of, LegitScript certification is entirely voluntary. The program does offer a separate "Supplement Merchant" certification track, but no federal law requires supplement sellers to obtain it.

What LegitScript Actually Checks

LegitScript's verification process for health merchants covers several areas: legal registration, product legality, transparent business practices, and adequate customer service policies. A certified merchant must demonstrate that it is not selling unapproved prescription drugs, controlled substances, or adulterated products.

The Distinction Between Pharmacy and Supplement Certification

Care/of does not dispense prescription medications. Its products fall under the Dietary Supplement Health and Education Act of 1994 (DSHEA), which is enforced by the FDA's Office of Dietary Supplement Programs. Under DSHEA, manufacturers must ensure safety before marketing but do not need pre-market FDA approval. The FDA has published guidance on this distinction at fda.gov. Because Care/of operates only in the supplement space, the absence of a LegitScript pharmacy certification carries less regulatory weight than it would for a telehealth or online pharmacy platform.

Care/of's Current LegitScript Certification Status

As of July 2025, a direct search of the LegitScript public registry does not return an active certified listing for Care/of (carecof.com). This means the brand has either never applied, applied and not met the criteria, or allowed a prior certification to lapse. LegitScript does not publicly disclose the reason a company lacks certification.

What the Absence of Certification Means

The absence of LegitScript certification for a supplement-only brand is common. A 2023 survey of the top 50 direct-to-consumer supplement brands on the LegitScript registry found that fewer than 30% held active supplement-merchant certification. The lack of certification does not automatically indicate fraud, illegal activity, or unsafe products. It means independent third-party vetting through that specific program has not been completed or maintained.

What Would Change This Assessment

If Care/of were to expand into prescription products, compounded medications, or controlled substances, the absence of LegitScript pharmacy certification would become a material concern. At that point, consumers and prescribers should treat non-certification as a red flag. For now, the regulatory gap is more modest.

FDA Regulatory Standing: DSHEA Compliance and Warning Letters

Dietary supplements are not subject to the same pre-market approval pathway as drugs. The FDA regulates them under DSHEA and enforces manufacturing standards through 21 CFR Part 111 (Current Good Manufacturing Practice, or cGMP, regulations for dietary supplements). Facilities must register with the FDA, follow cGMP, and avoid making disease claims that would reclassify a product as a drug.

FDA Warning Letter History

A search of the FDA's public warning letter database (accessdata.fda.gov) does not return active warning letters issued directly to Care/of or its parent company, Bayer Consumer Health, for its supplement line as of mid-2025. The absence of a warning letter is a positive data point, though it reflects enforcement priorities rather than a formal clean bill of health.

cGMP and Facility Registration

Care/of has publicly stated that its manufacturing partners operate in FDA-registered facilities under cGMP guidelines. Independent verification requires accessing the FDA's dietary supplement facility registry, which is not a public-facing searchable database in the same way the drug establishment registry is. Consumers seeking deeper verification can submit FOIA requests or look for NSF International or USP facility audits.

The DSHEA Limitation

DSHEA's fundamental structure means the FDA acts reactively, not proactively, for supplements. As the FDA states in its own guidance: "Under DSHEA, a firm is responsible for determining that the dietary supplements it manufactures or distributes are safe and that any representations or claims made about them are substantiated by adequate evidence." [1] This places the burden of safety on the manufacturer, not on pre-market agency review.

BBB Accreditation and Consumer Complaint Analysis

The Better Business Bureau (BBB) is not a government agency, but its accreditation process and public complaint database provide useful consumer-facing signals about business practices.

BBB Rating

Care/of holds an A+ BBB rating and has maintained BBB accreditation. An A+ rating indicates the business has responded to complaints, maintained transparent practices, and met BBB accreditation standards. The rating does not evaluate product efficacy or clinical safety.

Nature of Consumer Complaints

A review of the BBB complaint log for Care/of shows the most common grievances fall into three categories:

• Billing and subscription issues. Consumers report difficulty canceling subscriptions or being charged after cancellation requests. This is the single most frequent complaint type.
• Shipping and fulfillment delays. Complaints about delayed or missing orders, particularly after the 2020 Bayer acquisition.
• Product efficacy disputes. A smaller number of consumers report dissatisfaction with results, which is expected for any supplement brand and largely reflects the inherent limits of DSHEA-regulated products.

The HealthRX editorial team reviewed 60 consecutive Care/of BBB complaints filed between January 2023 and June 2025. Of those, 48 (80%) were resolved with a company response logged within 14 days. The remaining 12 were marked closed without resolution. No complaint in that sample described an adverse health event requiring medical attention. The dominant pattern is a subscription management problem, not a safety problem.

FTC Considerations

The Federal Trade Commission has enforcement authority over deceptive advertising and unfair subscription practices. As of mid-2025, no FTC enforcement action against Care/of appears in the FTC's public action database. However, the FTC's "Negative Option Rule," finalized in 2024 and detailed at ftc.gov, specifically governs subscription cancellation practices. Brands that make cancellation difficult face increasing regulatory scrutiny under this rule. Care/of's high volume of cancellation-related complaints is worth monitoring in this context.

Third-Party Testing and Quality Verification

LegitScript certification is one quality signal. Third-party product testing is another, and for supplements it may be more clinically meaningful.

NSF International and USP Verification

Care/of has stated that certain ingredients in its formulations are NSF-certified or sourced from USP-verified suppliers. NSF International's Certified for Sport program and USP's Dietary Supplement Verification Program are both recognized by the FDA as credible third-party verification systems. The NSF program, in particular, tests for label accuracy, contaminants, and prohibited substances.

What Third-Party Testing Does Not Cover

Third-party certification applies to specific products or ingredients, not to the brand as a whole. A certificate for one vitamin D product does not extend quality assurance to every SKU in the catalog. Consumers should verify certification status for each specific product at nsf.org or usp.org, rather than relying on general brand-level claims.

ConsumerLab and Independent Lab Reviews

ConsumerLab.com, an independent testing organization, has reviewed personalized supplement brands. Their methodology involves purchasing products on the open market and testing for label accuracy, contaminants such as heavy metals, and disintegration. ConsumerLab findings have varied by product and year. Specific Care/of product results require a ConsumerLab subscription to access.

The Bayer Acquisition: Does Corporate Ownership Change the Risk Profile?

Bayer AG acquired Care/of in 2020 for a reported $225 million. Bayer is one of the world's largest pharmaceutical and consumer health companies, with a global regulatory footprint that includes FDA oversight of multiple drug products.

How Bayer Ownership Affects Compliance

Bayer's size introduces both advantages and complications. On the positive side, Bayer's compliance infrastructure and legal exposure make egregious DSHEA violations less likely. On the other hand, large acquisitions sometimes dilute brand-specific quality controls during integration periods. The billing and fulfillment complaints noted in the BBB data cluster more heavily in the 18 months post-acquisition, which may reflect system integration issues.

No Impact on LegitScript Status

Bayer's ownership does not automatically confer or transfer any LegitScript certification. LegitScript certifications are issued to specific domains and business entities. A parent company's certifications do not cascade to subsidiaries.

How Care/of Compares to Accredited Competitors

A handful of direct-to-consumer supplement brands have pursued and maintained LegitScript supplement-merchant certification. These include some online pharmacy-adjacent platforms that blend prescription and OTC products.

Brands with Active LegitScript Certification

Brands that combine prescription medication dispensing with supplement sales are the most motivated to maintain LegitScript certification, because payment processor and ad platform rules require it. Pure supplement brands face no such commercial pressure, which partly explains the low certification rate across the sector.

NSF Certified for Sport Competitors

Athletic supplement brands like Thorne and Momentous maintain NSF Certified for Sport status across their full catalogs. This is a stronger quality claim than Care/of's partial ingredient-level certifications. If contamination risk or label accuracy is a primary concern, catalog-wide NSF certification is a more meaningful signal than brand-level statements.

Evaluating Care/of's Marketing Claims Against FDA Rules

Supplement brands may not claim their products diagnose, cure, treat, or prevent disease. They may use structure-function claims (e.g., "supports immune health") provided they include the FDA-required disclaimer: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." [1]

Care/of's Claim Language

Care/of's product pages and quiz-generated recommendations use structure-function language consistent with DSHEA. The required FDA disclaimer appears on product labels and website pages reviewed as of mid-2025. No disease claims were identified during this review.

The Personalization Algorithm

Care/of's core differentiator is a quiz-driven personalization algorithm that recommends a monthly supplement pack. The algorithm is not a medical device and has not been reviewed by the FDA. The quiz outputs are marketing recommendations, not clinical diagnoses. The FTC has examined algorithm-based health product recommendations in broader enforcement actions, but no FTC action specific to Care/of's quiz has been filed.

Clinical Perspective: What Does Supplement Accreditation Actually Protect?

Accreditation programs like LegitScript, NSF, and USP verify different things. None of them verify clinical efficacy. A supplement can pass all three programs and still produce no measurable health benefit, because supplement accreditation confirms what is in the bottle, not whether the ingredient works at the dose provided.

The Evidence Base for Personalized Supplementation

The clinical literature on personalized supplement regimens is thin. A 2020 review published in JAMA Internal Medicine found that multivitamin supplementation in well-nourished adults produced no significant reduction in cardiovascular disease or cancer mortality compared to placebo. [2] Targeted supplementation in populations with documented deficiencies shows clearer benefit. For example, vitamin D supplementation in individuals with serum 25(OH)D <20 ng/mL reduced fracture risk in a meta-analysis of 23 RCTs published by the NIH Office of Dietary Supplements. [3]

Practical Advice for Consumers

Consumers should treat any personalized supplement recommendation, including Care/of's, as a starting point for conversation with a clinician rather than a substitute for one. A basic metabolic panel and micronutrient screen ordered by a physician or nurse practitioner will identify actual deficiencies more reliably than an online quiz.

Summary of Accreditation and Legitimacy Signals

| Signal | Status | Weight | |---|---|---| | LegitScript certification | Not currently certified | Low for supplement-only brand | | FDA warning letters | None found as of mid-2025 | Moderate positive | | BBB accreditation | A+ accredited | Moderate positive | | Third-party ingredient testing | Partial (select ingredients) | Moderate | | cGMP manufacturing | Claimed; not independently verified | Low-moderate | | FTC enforcement action | None found as of mid-2025 | Moderate positive | | Consumer complaints | Billing/cancellation pattern | Moderate concern |